{
  "id": "b17c1da8c48ca9ec",
  "title": "Uplizna Gains FDA Approval for Generalized Myasthenia Gravis",
  "description": "20251219T171500Z",
  "content": "",
  "source": "neurologyadvisor.com",
  "source_url": "https://www.neurologyadvisor.com/news/uplizna-gains-fda-approval-for-generalized-myasthenia-gravis/",
  "published_at": "20251219T171500Z",
  "fetched_at": "2025-12-20T00:22:03.659749+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "ai"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.neurologyadvisor.com/news/uplizna-gains-fda-approval-for-generalized-myasthenia-gravis/",
    "url_mobile": "",
    "title": "Uplizna Gains FDA Approval for Generalized Myasthenia Gravis",
    "seendate": "20251219T171500Z",
    "socialimage": "https://www.neurologyadvisor.com/wp-content/uploads/sites/10/2024/12/Neurology.png",
    "domain": "neurologyadvisor.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}